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Abstract 
Suppression of the growth hormone/insulin-like growth factor-I pathway in Ames dwarf 
(DF) mice, and caloric restriction (CR) in normal mice extends lifespan and delays the 
onset of age-related disorders. In combination, these interventions have an additive 
effect on lifespan in Ames DF mice. Therefore, common signaling pathways regulated 
by DF and CR could have additive effects on longevity. In this study, we tried to 
identity the signaling mechanism and develop a system to assess pro-longevity status in 
cells and mice. We previously identified genes up-regulated in the liver of DF and CR 
mice by DNA microarray analysis. Motif analysis of the upstream sequences of those 
genes revealed four major consensus sequence motifs, which have been named 
dwarfism and calorie restriction-responsive elements (DFCR-REs). One of the 
synthesized DFCR-RE sequences bound to hepatocyte nuclear factor-4 (HNF-4), an 
important transcription factor involved in liver metabolism. Furthermore, using this 
sequence information, we developed a highly sensitive bioassay to identify chemicals 
mimicking the anti-aging effects of CR. When the reporter construct, containing an 
element upstream of a secreted alkaline phosphatase (SEAP) gene, was co-transfected 
with HNF-4 and its regulator peroxisome proliferator-activated receptor (PPAR) 
coactivator-1 (PGC-1), SEAP activity was increased compared with untransfected 
controls. Moreover, transient transgenic mice established using this construct showed 
increased SEAP activity in CR mice compared with ad libitum-fed mice. These data 
suggest that because of its rapidity, ease of use, and specificity, our bioassay will be 
more useful than the systems currently employed to screen for CR mimetics, which 
mimic the beneficial effects of CR. Our system will be particularly useful for 
high-throughput screening of natural and synthetic candidate molecules. 
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Abbreviations: AL: ad libitum, CR: calorie restriction, CRISP:  calorie restriction 
imitating chemicals searching platform, DF: dwarf, DFCR-RE: dwarfism and calorie 
restriction-responsive element, HNF-4: hepatocyte nuclear factor-4, PGC-1: 
peroxisome proliferator-activated receptor (PPAR)  coactivator-1. SEAP: secreted 
alkaline phosphatase. 
1. Introduction 
Spontaneous mutations and genetic modifications of growth hormone (GH) 
and suppression of the plasma concentration of insulin-like growth factor-I (IGF-I) 
produce a dwarf (DF) phenotype and extend the lifespan of rodents (see review [1-3]). 
Ames DF mice, which are homozygous for a loss of function mutation at the Prop1 
locus, which is important for pituitary development, exhibit a 40–70% increase in 
lifespan compared with normal heterozygous mice [1-3]. Similarly, caloric restriction 
(CR), in which dietary caloric intake is reduced without causing malnutrition, retards 
aging and age-related diseases, and increases lifespan in a variety of organisms [1-3]. 
The lifespan promoting effects of DF and CR could be mediated through the same or 
related pathways that are more strongly affected by a combination of both interventions, 
or through distinct molecular pathways that are independently affected by each 
intervention. Bartke et al [4] suggested that different molecular mechanisms were 
responsible for the prolonged longevity of Ames DF mice and CR mice. However, they 
also showed that knockout of the GH receptor gene (GHRKO) in mice suppressed the 
lifespan extending effect of CR [5]. These results suggest that GHRKO and CR 
influence lifespan through the same pathway. We previously observed an additive 
longevity effect of DF and CR in GH-antisense transgenic rats [6]. That study revealed 
that CR affects aging predominantly via mechanisms other than suppression of the 
GH–IGF-I axis in this model. These results suggest that, at least in part, suppression of 
the GH–IGF-I axis is important for longevity. However, other signaling pathways are 
also important in the anti-aging effects of CR, and the additive longevity effects on DF 
and CR could be dependent on strain and species.  
To gain insight into the signaling pathways activated by DF in combination 
with CR, we previously analyzed the hepatic gene expression profiles in normal and 
Ames DF mice subjected to ad libitum (AL) or CR diets using oligonucleotide 
microarrays [7]. We found that 56 genes were up-regulated by the DF and CR, and that 
the effects of DF and CR were additive. That study suggested that the additive effects of 
DF and CR on lifespan are achieved by their additive effects on the expression of genes 
involved in the regulation of detoxification, oxidative stress, and protein quality control. 
The study also suggested that DF and CR also might promote longevity through their 
independent effects on the expression of other genes.  
CR might be effective for human longevity, but it is difficult to continue CR 
in our daily lives because of the ensuing perpetual state of hunger. In addition, we do 
not know the degree or length of restriction required to elicit meaningful effects in 
humans. Thus, research in this field is focusing on the development of molecules that 
mimic the beneficial effects of CR without reducing food intake [8, 9]. The candidates 
molecules include synthetic chemical compounds and plant-derived functional 
chemicals (phytochemicals) [10], and some of molecules are currently being tested in 
clinical trials as anti-diabetic drugs. These studies hold great promise to improve the 
quality of life of elderly people. Thus, the development of an efficient system to screen 
CR mimetics would undoubtedly accelerate and expand research in this field. 
The secreted alkaline phosphatase (SEAP) reporter system has been widely 
used to investigate the activity of known or putative enhancer/promoter elements [11]. 
To construct a reporter vector, we need to identify the regulatory sequence elements of 
the target genes. Approaches for regulatory motif discovery have been described that 
extract upstream regulatory sequences from microarray-derived yeast expression data 
[12]. In the present study, we used a similar method to identify the regulatory elements 
of putative pro-longevity genes up-regulated in both DF and CR. Up-regulation of these 
co-regulated genes seem likely to activate the pathways that increase lifespan. Here, we 
describe the motifs identified using this approach, and the development of an efficient 
bioassay to screen candidate CR mimetics.  
2. Materials and Methods 
2.1. Motif isolation 
We previously identified 56 genes that were additively up-regulated in the 
liver of DF and CR mice [7]. The 5’ untranslated regions of these genes (3000 bp from 
the open reading flame) were isolated using EZ Retrieve [13] 
(http://siriusb.umdnj.edu:18080/EZRetrieve/index.jsp). The sequences of 43 of these 
genes were isolated and consensus motifs of these sequences were analyzed using 
MEME [14] (http://meme.sdsc.edu/meme/cgi-bin/meme.cgi). The results for the four 
most highly conserved motifs (except for putative repetitive sequence) are shown as a 
sequence logo generated using WebLogo (http://weblogo.berkeley.edu/) [14]. 
 
2.2. Cell culture 
CHO cells and 293 cells were purchased from the American Type Culture 
Collection. The cells were maintained in Dulbecco’s modified minimum essential 
medium (D-MEM; Wako) supplemented with 10% fetal bovine serum (Sigma-Aldrich), 
100 U/mL penicillin and 100 g/mL streptomycin (Nacalai Tesque). Incubation and 
isolation of protein samples were performed as previously described [15, 16]. 
 
2.3. Gel shift assay 
The gel shift assay was performed essentially as previously described [17, 18]. 
Probe DNAs best describing the isolated motifs were synthesized. Double-stranded 
DNA probes were end-labeled with [•-32P]ATP and T4 polynucleotide kinase 
(Amersham Biosciences). The sequences of the probes are as follows: DFCR-RE1 
(5’-AGACCAGGCTGGCCT-3’), DFCR-RE2 
(5’-AGCACTTGGGAGGCAGAGGCAGGGGGAG-3’), DFCR-RE3 
(5’-CTGCCTCTGCCTCCC-3’), and DFCR-RE4 
(5’-AGTGAGTTCCAGGCCAGCCAG-3’). Five micrograms of nuclear extract (CHO 
cell or mouse liver) was incubated with 1 g of poly(dI-dC) (Roche Diagnostics), 
followed by the addition of the end-labeled oligonucleotide (8 fmol). Samples were then 
incubated at room temperature for 30 min in binding buffer (20 mM Hepes pH 7.9, 50 
mM KCl, 5% glycerol, 1 mM EDTA, 10 mM DTT). The HNF-4 binding assay was 
performed as follows. HNF-4 protein was produced in vitro using a TNT Quick 
Coupled Transcription/Translation System (Promega). Double-stranded DNA probes 
(DFCR-RE2) were biotin-labeled using a LightShift Chemiluminescent EMSA Kit 
(Pierce Biotechnology). In vitro transcribed/translated HNF-4 (4 L) was incubated 
with 1 g of poly(dI-dC), followed by the addition of biotin-labeled oligonucleotide (40 
fmol), and incubated at room temperature for 30 min in binding buffer (10 mM Tris pH 
7.5, 60 mM KCl, 4 mM MgCl, 12% glycerol, 1 mM EDTA, 2 mM DTT, 20 mM PMSF). 
Anti-Flag monoclonal antibody M2 (Sigma-Aldrich, 5 g) was added for supershift, or 
4 pM (100-fold excess) of unlabeled competitor DNA was added to confirm binding 
specificity. The reaction mixtures were loaded onto 5% nondenaturing polyacrylamide 
gels containing 1× TBE (90 mM Tris-HCl pH 8.0, 89 mM boric acid, 2 mM EDTA). 
After electrophoresis for 2 h at 100 V at room temperature, the radioactive gels were 
dried and analyzed with an image analyzer [19, 20]. For chemiluminescence detection 
of the biotinylated probes, the DNA/protein complex was transferred to a nylon 




Expression vectors for HNF-4 and PGC-1 were kind gifts from Dr. 
Shimano (Tsukuba) and Dr. Spiegelman (Harvard), respectively. The pcDNA3 vector 
(Invitrogen) was used as an empty vector control. Five copies of the DFCR-RE2 
sequence were subcloned into the NheI/BglII site of pSEAP2-Control (Clontech), and 
pDFCR-RE2-SEAP was constructed. The secreted luciferase gene containing 




Weaned 6-week-old male ICR mice (Slc:ICR) were purchased from Japan 
SLC, and housed in our specific-pathogen-free facility under temperature- and 
light-controlled conditions (21–24°C, 12-h light/dark cycle). Animal care and 
experimental procedures were performed in accordance with the Guidelines for Animal 
Experimentation of Nagasaki University, and were approved by the Institutional Animal 
Care and Use Committee. Mice were fed AL with a CR-LPF diet (Oriental Yeast). From 
12 weeks of age, mice were divided into two groups: one group was fed AL, and the 
other group was subjected to CR (70% calorie intake). CR was performed as previously 
described [21].  
 
2.6. In vitro reporter assay 
Subconfluent 293 cells plated on six-well plates were used for the in vitro 
reporter assay. Transfection was performed using FuGENE HD Transfection Reagent 
(Roche Diagnostics). pDFCR-RE2-SEAP and pMetLuc-Control plasmid were included 
in each transfection experiment with or without HNF-4 and PGC-1 expression 
vectors. The total transfected DNA content was adjusted to 3 g by the addition of 
pcDNA3 vector. Before and 2 days after transfection, the medium was collected and 
SEAP and luciferase activities were measured as described below. 
 
2.7. In vivo reporter assay 
Twenty-eight-week-old ICR mice were used for the in vivo reporter assay. 
Using a TransIT-EE Hydrodynamic Delivery Solution (Mirus Bio), 10 g of 
pDFCR-RE2-SEAP and 5 g of pMetLuc-Control plasmid were introduced to the 
mouse liver. Before and 2 days after injection, blood samples were collected and SEAP 
and luciferase activities were measured as described below. 
 
2.8. SEAP and luciferase activity assay 
SEAP and luciferase activities in the conditioned media and sera were 
evaluated by a chemiluminescent method using the Ready-To-Glow Dual Secreted 
Reporter Assay kit (Clontech). In brief, for the SEAP assay, 25 L of cell culture 
medium from transfected cells or serum (undiluted or diluted 10-fold with PBS, 
respectively) was mixed with 75 L of 1× dilution buffer and incubated for 30 min at 
65°C to inactivate endogenous alkaline phosphatase. After incubation, the samples were 
mixed with 100 L of SEAP substrate solution, and left at room temperature for 30 min. 
SEAP activity was then assessed using a luminometer (AccuFLEXLumi 400, Aloka). 
For the luciferase assay, 50 L of cell culture medium from transfected cells or serum 
(undiluted or 10-fold diluted with PBS, respectively) was mixed with 5 L of 1× 
substrate/reaction buffer and incubated for 10 min at room temperature. Luciferase 
activity was then assessed using a luminometer. All assays were performed in duplicate. 
 
2.9. Statistical analysis 
All experiments were repeated at least three times. Data are expressed as 
means ± standard deviation (SD). Statistical analysis of the in vivo reporter assay was 
performed using Student’s t test to compare each group. A p value of < 0.05 was 
considered to indicate a statistically significant difference. 
 
3. Results and Discussion 
Fig. 1 shows the isolated motifs of the putative pro-longevity genes. We 
generated dsDNAs best describing these motifs (Supplement Table S1) and performed 
gel shift assays. As shown in Fig. 2, the nuclear proteins bound to these sequences, 
particularly DFCR-RE2 and 4 (marked by an asterisk). Supplementary Table S2 lists the 
gene containing DFCR-RE2 motifs in their up-stream region. As reported previously [7], 
most of these genes are related to the regulation of metabolism, detoxification, oxidative 
stress, and protein quality control. Some of these genes have been shown to be under the 
control of PGC-1, an important transcriptional regulator in liver [22]. The major target 
transcriptional factors of PGC-1 are HNF-4, FoxO1 and Nrf2, and we have recently 
shown the importance of HNF-4 [23] and FoxO1 [21] in the effects of CR. Importantly, 
HNF-4, FoxO1 could interact and regulate the transcription of HNF-4 target genes 
[18]. Furthermore, we found that DFCR-RE2 showed some homology to a HNF-4 
binding motif identified in an earlier study [17]. Therefore, we next assessed whether 
HNF-4 could bind to the DFCR-RE2 sequence. As shown in Fig. 3, the in vitro 
translated Flag-tagged HNF-4 protein could bind to DFCR-RE2. This binding was 
reduced by the addition of anti-Flag antibody, probably due to steric blocking of the 
DNA binding region of HNF-4 by the antibody. Moreover, the addition of unlabeled 
competitor DNA diminished the shifted band. These results suggest the DNA/protein 
interaction is specific, although mutational analysis of DFCR-RE2 will be needed to 
further validate this specificity and to identify the sequences crucial for this binding.  
We constructed a reporter assay system using DFCR-RE2 linked upstream of 
the SEAP gene . As shown in Fig. 4A, SEAP activity was dose-dependently increased 
by HNF-4/PGC-1 transfection in 293 cells. These results support the notion that 
DFCR-RE2 binds to and is activated by HNF-4/PGC-1 in vitro. Because DFCR-RE2 
is a relatively long sequence for an enhancer element, other factors might also play 
important roles in its transcriptional transactivation. This appears likely, since our 
previous results in CR rats [23] demonstrated that CR increases the interaction between 
HNF-4 and PGC-1 in the liver, and increases the expression of target genes, such as 
phosphoenolpyruvate carboxykinase. The mRNA for this gene is also increased in the 
liver of CR and DF mice (Supplementary Table S2). The SEAP reporter assay can be 
used for in vivo studies because secreted SEAP can be detected in mouse serum. 
Therefore, we investigated whether this reporter construct is activated in the liver of CR 
mice. As shown in Fig. 4B, SEAP activity was significantly greater in CR mice than in 
AL mice. Although we still need to conduct mutational studies of DFCR-RE, these 
results indicate that DFCR-RE2 is activated by CR in the liver. The construction of 
combined DFCR-RE reporters, such as a reporter with DFCR-RE2 linked in cis with 
DFCR-RE4, might increase their responsiveness to CR mimetics. These motifs may act 
in concert to transactivate their target genes. 
Kurachi et al [24, 25] identified an age-related stability element (ASE) that 
regulates age-related gene expression. They found an ASE, (C/G)AGGAAG, containing 
an Ets transcription factor consensus motif (GGAA), that was bound specifically by 
Ets1. Interestingly, DFCR-RE2 contains two sequences similar to this ASE, namely 
GAGGCAG, in its middle region. Mutational studies demonstrated that this sequence 
(GAGGCAG) does not bind to any proteins present in nuclear extracts, including Ets1 
[25]. Further studies are needed to determine whether there is a functional relationship 
between the ASE and DFCR-RE2. Because loss of the ASE causes an age-related 
decline in gene expression, DFCR-RE2 might regulate stable gene expression for the 
entire lifespan of an animal. Therefore, DF and CR might have similar functions. They 
may stabilize (suppress down-regulation) or up-regulate target genes containing the 
DFCR-RE2. Such regulation would avoid the age-related reductions in gene expression 
which appear to result in age-related functional decline.  
DRESSA (dioxin-responsive-element-based sensing via secreted alkaline 
phosphatase) has been used to detect toxic materials in assays similar to the SEAP assay 
described here [11]. The advantages of these assays have been widely reported. For 
these reasons, we adapted this strategy to identify molecules offering potential health 
benefits. Because DFCR-REs were isolated from long-lived mice, the transcriptional 
regulators of this sequence could be beneficial for longevity. We found that our 
DFCR-RE2 reporter construct was up-regulated in CR mice. Hence, compounds that 
activate this reporter may be candidate CR mimetics.  
Using the approach described here, we can analyze the effects of candidate 
molecules by adding them to the culture medium in vitro or mixing them with mouse 
food for in vivo studies. Our approach could be used to identify activators and well as 
inhibitors of the negative regulator of this element. Therefore, our approach offers 
advantages compared with the single molecule targeted methods. Sirtuin activators such 
as resveratrol and other small molecules were thought to be promising candidates for 
CR mimetics [10]. However, recent studies have revealed the limitations of the sirtuin 
activator screening system [26, 27]. One limitation is that the screening system was 
established as an in vitro, cell-free system that targeted a single protein, SIRT1. 
Furthermore, the studies used a problematic fluorescently labeled substrate which 
produce non-specific SIRT1 activation. Our strategy offers distinct advantages because 
it can be performed in vitro or in vivo, and is not limited in terms of possible candidate 
molecules because a target protein is not specified in this assay. The present results 
suggest that mice transgenic for DFCR-RE-SEAP reporter genes will provide an even 
more convenient vehicle for in vivo screening of CR mimetics. 
 
4. Conclusions 
Here, we have described a rapid and highly sensitive bioassay that is expected 
to help screen potential anti-aging agents (CRISP: calorie restriction imitating 
chemicals searching platform), such as drugs, including traditional Chinese medicines, 
and phytochemicals in vitro and in vivo. Molecules identified by this assay could 
ultimately be used to treat metabolic diseases such as diabetes, cancer and 
neurodegenerative diseases because of the properties of CR mimetics [8, 9]. Because of 
its ease of use, specificity, and time- and cost-effectiveness, the approach described here 
is expected to be more useful than other currently available screening systems and 
would be particularly suited to high-throughput screening of CR mimetics. 
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Fig. 1. Motifs identified by analyzing the combined effects of dwarfism and calorie 
restriction. The four most significant motifs are shown. The identified motif matrices 
are represented as a sequence logo. 
 
Fig. 2. Identification of dwarfism and calorie restriction response element 
(DFCR-RE)-binding nuclear proteins. A gel shift assay was performed using nuclear 
extracts from mouse liver (lanes 3, 6, 9 and 12) and CHO cells (lanes 2, 5, 8 and 11), or 
in the absence of protein (lanes 1, 4, 7 and 10). Lane 1–3 contain the 32P-labeled 
DFCR-RE1 probe, lanes 4–6 contain the 32P-labeled DFCR-RE2 probe, lanes 7–9 
contain the 32P-labeled DFCR-RE3 probe, and lanes 10–12 contain the 32P-labeled 
DFCR-RE4 probe. Asterisk: major shifted bands; arrowhead: free probe.  
 
Fig. 3. The dwarfism and calorie restriction-response element 2 (DFCR-RE2) is a 
binding site for HNF-4. A gel shift assay was performed to detect specific interactions 
between the DFCR-RE2 sequence and HNF-4. A biotin-labeled DFCR-RE2 probe was 
incubated with (lane 2–4) or without (lane 1) the in vitro translation product of HNF-4. 
Anti-Flag antibody (5 g, lane 3) or a 100-fold molar excess of unlabeled competitor 
DNAs (lane 4) were added to confirm specific binding. Asterisk: shifted band 
corresponding to the HNF-4–DNA complex; arrowhead: free probe.  
 
Fig. 4. (A) The dwarfism and calorie restriction-response element 2 (DFCR-RE2) is 
activated by HNF-4/PGC-1 in vitro. 293 cells were transfected with a secreted 
alkaline phosphatase (SEAP) reporter, pDFCR-RE2-SEAP (500 ng) and 
pMetLuc-Control plasmid (500 ng) in the presence of HNF-4 (500 ng) alone or 
HNF-4 with PGC-1 (500 ng or 1 g each) or empty vectors (adjusted total DNA, 3 
•g). Values are normalized to the internal control, secreted luciferase activity. Results 
are presented as relative SEAP activity (means ± SD). (B) Activation of DFCR-RE2 by 
CR in vivo. Transient transgenic reporter mice (35–55 g body weight; five male mice 
per group) fed AL or CR. At 28 weeks of age, the mice were injected with 10 g of 
pDFCR-RE2-SEAP and 5 g of pMetLuc-Control vector by the hydrodynamic method. 
Values are normalized to the internal control secreted luciferase activity. Results are 
presented as relative SEAP activity (means ± SD). Statistically significant differences 
were observed between the AL and CR groups (p < 0.05). 
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Supplementary Table S1. DFCR-RE probe sequences best describing the motifs 
shown in Fig. 1. 
 Motif 1 AGACCAGGCTGGCCT 
DFCR 
Motif 2 AGCACTTGGGAGGCAGAGGCAGGGGGAG 
Motif 3 CTGCCTCTGCCTCCC 
 Motif 4 AGTGAGTTCCAGGCCAGCCAG 
 
Supplementary Table S2. Genes containing the DFCR-RE2 sequence 
Accession number Gene Function Fold-change 
J03952 Gstm1 Phase II protein 1.4 
AW047116 Rpl37 Ribosomal protein 1.4 
AI854771  EST 1.4 
U73039 Nbr1 Unknown 1.4 
AB017616 Rragc GTP binding protein 1.4 
AJ245569 Dennd5a Unknown 1.4 
Y13087 Casp6 Apoptosis 1.4 
AI852608  EST 1.5 
Z54179 Gtl3 Unknown 1.5 
AI854482  EST 1.5 
M32032 Selenbp1 Selenium metabolism 1.5 
AF093140 Nxf1 Nuclear RNA export factor 1.5 
AI846123 Grsf1 RNA binding factor 1.5 
U96116 Hadh2 Lipid metabolism  1.5 
U89491 Ephx1 Phase II protein 1.5 
AW125626 Cnn3 Cytoskeleton 1.5 
AI838709 Spnr RNA binding protein 1.5 
X74938 Foxa3 Gluconeogenesis 1.6 
U85414 Gclc Anti-oxidant 1.6 
AF009605 Pck1 Gluconeogenesis 1.6 
M27168 Cyp2d9 Phase I protein 1.6 
AF080580 Clk-1 Respiratory chain 1.6 
Z37107 Ephx2 Phase II protein 1.6 
AI846938 Herpud1 Protein degradation 1.6 
Z50159 Elf1 Translation initiation factor 1.6 
U90535 Fmo5 Phase I protein 1.7 
AI843802 Lpin2 Lipid metabolism 1.7 
L21221 Pcsk4 Serine protease 1.7 
Z22216 Apoc2 Lipid metabolism 1.8 
J03953 Gstm3 Phase II protein 2.0 
AW124049  EST 2.3 
X53451 Gstp2 Phase II protein 2.3 
X81580 Igfbp2 Growth suppression 3.0 
AB016424 Rbm3 RNA binding protein 3.5 
AI853773 Fbxo21 Protein degradation 3.7 
GenBank accession number, gene name, function, and fold up-regulation versus control 
are shown based on results of our previous study [7]. EST: expression sequence tag. 
